IL253125A0 - Tetracaine-based formulations for use as an anesthetic - Google Patents
Tetracaine-based formulations for use as an anestheticInfo
- Publication number
- IL253125A0 IL253125A0 IL253125A IL25312517A IL253125A0 IL 253125 A0 IL253125 A0 IL 253125A0 IL 253125 A IL253125 A IL 253125A IL 25312517 A IL25312517 A IL 25312517A IL 253125 A0 IL253125 A0 IL 253125A0
- Authority
- IL
- Israel
- Prior art keywords
- tetracaine
- anesthetic
- based formulations
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
- A61M11/007—Syringe-type or piston-type sprayers or atomisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M19/00—Local anaesthesia; Hypothermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
- A61M11/008—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised by squeezing, e.g. using a flexible bottle or a bulb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/0007—Special media to be introduced, removed or treated introduced into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0468—Liquids non-physiological
- A61M2202/048—Anaesthetics
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462096287P | 2014-12-23 | 2014-12-23 | |
PCT/US2015/000209 WO2016105482A1 (en) | 2014-12-23 | 2015-12-23 | Tetracaine-based anesthetic |
Publications (1)
Publication Number | Publication Date |
---|---|
IL253125A0 true IL253125A0 (en) | 2017-08-31 |
Family
ID=55237886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL253125A IL253125A0 (en) | 2014-12-23 | 2017-06-22 | Tetracaine-based formulations for use as an anesthetic |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP3236941A1 (en) |
JP (1) | JP2017538777A (en) |
KR (1) | KR20170102892A (en) |
CN (1) | CN107249568A (en) |
AU (1) | AU2015371291A1 (en) |
BR (1) | BR112017013373A2 (en) |
CA (1) | CA2971156A1 (en) |
EA (1) | EA201791448A1 (en) |
IL (1) | IL253125A0 (en) |
MX (1) | MX2017008516A (en) |
WO (1) | WO2016105482A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019191200A1 (en) | 2018-03-27 | 2019-10-03 | American Genomics, Llc | Method and formulation for producing anesthesia of internal aspect of eye wall by topical application |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2413899T3 (en) * | 2009-04-03 | 2021-04-19 | St Renatus Llc | Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration |
-
2015
- 2015-12-23 EA EA201791448A patent/EA201791448A1/en unknown
- 2015-12-23 KR KR1020177019688A patent/KR20170102892A/en unknown
- 2015-12-23 AU AU2015371291A patent/AU2015371291A1/en not_active Abandoned
- 2015-12-23 WO PCT/US2015/000209 patent/WO2016105482A1/en active Application Filing
- 2015-12-23 CA CA2971156A patent/CA2971156A1/en not_active Abandoned
- 2015-12-23 MX MX2017008516A patent/MX2017008516A/en unknown
- 2015-12-23 JP JP2017533578A patent/JP2017538777A/en active Pending
- 2015-12-23 BR BR112017013373A patent/BR112017013373A2/en not_active Application Discontinuation
- 2015-12-23 CN CN201580075138.0A patent/CN107249568A/en active Pending
- 2015-12-23 EP EP15828784.7A patent/EP3236941A1/en not_active Withdrawn
-
2017
- 2017-06-22 IL IL253125A patent/IL253125A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR112017013373A2 (en) | 2018-01-02 |
MX2017008516A (en) | 2017-09-19 |
WO2016105482A9 (en) | 2017-08-03 |
EP3236941A1 (en) | 2017-11-01 |
EA201791448A1 (en) | 2017-11-30 |
CA2971156A1 (en) | 2016-06-30 |
KR20170102892A (en) | 2017-09-12 |
AU2015371291A9 (en) | 2017-08-24 |
AU2015371291A1 (en) | 2017-08-03 |
JP2017538777A (en) | 2017-12-28 |
WO2016105482A1 (en) | 2016-06-30 |
CN107249568A (en) | 2017-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL246978A0 (en) | Novel pharmaceutical formulations | |
GB2545368B (en) | Diversion-resistant opioid formulations | |
IL247072A0 (en) | Medical use | |
GB201407934D0 (en) | Formulation | |
GB201419261D0 (en) | Formulations | |
GB201419091D0 (en) | Formulations | |
GB201421162D0 (en) | Lanthanide complex formulations | |
HK1254980A1 (en) | Blended formulations | |
PL3184492T3 (en) | Antiseptic formulation | |
HK1232121A1 (en) | Fullerene compounds as antioxidant therapy | |
IL248835B (en) | Ceritinib formulation | |
IL247828A0 (en) | Progesterone formulations | |
GB201407384D0 (en) | Formulation | |
IL251362A0 (en) | Formulation | |
SG11201608123VA (en) | Pharmaceutical composition for external use | |
GB201417589D0 (en) | Pharmaceutical Formulations | |
IL253125A0 (en) | Tetracaine-based formulations for use as an anesthetic | |
GB201407051D0 (en) | Veterinary composition | |
GB201402448D0 (en) | Novel formulation | |
PL3017799T3 (en) | Patient table | |
GB201511301D0 (en) | Formulation | |
SG11201608124XA (en) | Pharmaceutical composition for external use | |
IL251664A0 (en) | Inhalable formulation | |
SG11201608122PA (en) | Pharmaceutical composition for external use | |
GB201511478D0 (en) | Blended formulations |